Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii
Clinical trials sponsored by Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Common painkiller ibuprofen tested as treatment for heart inflammation Results expected Apr 2027 (estimated)
-
Butter and bacon for a stronger heart? new trial puts high-fat diet to the test.
Disease control Recruiting nowThis study tests whether a carefully controlled high-fat diet can improve heart function in people with a specific type of heart failure (non-ischemic dilated cardiomyopathy). Researchers believe that switching the heart's fuel source back to fats may help it pump more effectivel…
Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Common painkiller ibuprofen tested as treatment for heart inflammation
Disease control Recruiting nowThis clinical trial is testing whether a 3-week course of ibuprofen can reduce heart scarring better than standard acetaminophen in people hospitalized with acute myocarditis (heart muscle inflammation). The study will enroll 150 adults with mild cases (normal heart pumping funct…
Phase 3 • Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Simple cuff trick may shield hearts from chemo damage
Disease control Recruiting nowThis study tests whether temporarily stopping blood flow in the arm with a blood pressure cuff can protect the hearts of lymphoma patients receiving chemotherapy. The procedure, called remote ischemic preconditioning, is done before each chemo session. Researchers will compare he…
Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III • Aim: Disease control
Last updated Jun 26, 2026 18:39 UTC